Iris Chang
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- Immunology and Allergy top 5%
- Food Allergy and Anaphylaxis Research
Papers in
-
- COVID-19 Clinical Research Studies 11
- SARS-CoV-2 and COVID-19 Research 10
-
- Food Allergy and Anaphylaxis Research 5
- Co-authors
- Xiaoying Zhou (2 shared papers)Xiaorui Han (2 shared papers)Shu Cao (2 shared papers)Kari Christine Nadeau (5 shared papers)Bryan Bunning (1 shared paper)Shu‐Chen Lyu (1 shared paper)Vanitha Sampath (1 shared paper)Laurie Elizabeth Kost (1 shared paper)
- Journals
- Allergy (5 papers)Nature Communications (4 papers)JCI Insight (2 papers)Science Translational Medicine (2 papers)Cell Reports Medicine (2 papers)
- Partner nations
- United StatesSwitzerlandTürkiye
In The Last Decade
Iris Chang
25 papers receiving 1.3k citations
Iris Chang's Hit Papers
Peers
Comparison fields: 5 of 82
- Infectious Diseases 737
- Immunology and Allergy 106
- Neurology 178
- Immunology 221
- General Dentistry 3
Countries citing papers authored by Iris Chang
This map shows the geographic impact of Iris Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iris Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iris Chang more than expected).
Fields of papers citing papers by Iris Chang
This network shows the impact of papers produced by Iris Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iris Chang. The network helps show where Iris Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Iris Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | New-onset IgG autoantibodies in hospitalized patients with COVID-19 Hit paper breakdown → | 2021 | 371 |
| 2 | Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination Hit paper breakdown → | 2022 | 344 |
| 3 | 2021 | 165 | |
| 4 | 2021 | 105 | |
| 5 | 2021 | 59 | |
| 6 | 2021 | 39 | |
| 7 | 2024 | 38 | |
| 8 | 2023 | 33 | |
| 9 | 2022 | 30 | |
| 10 | RELMβ sets the threshold for microbiome-dependent oral tolerance Hit paper breakdown → | 2025 | 30 |
| 11 | 2022 | 29 | |
| 12 | 2023 | 26 | |
| 13 | 2022 | 25 | |
| 14 | 2024 | 16 | |
| 15 | 2024 | 14 | |
| 16 | 2024 | 13 | |
| 17 | 2022 | 9 | |
| 18 | 2025 | 9 | |
| 19 | 2024 | 5 | |
| 20 | 2024 | 5 |
About Iris Chang
Iris Chang is a scholar working on Infectious Diseases, Immunology and Allergy, Immunology, Neurology and Pharmacology, having authored 30 papers that have together received 1.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (11 papers), SARS-CoV-2 and COVID-19 Research (10 papers), Food Allergy and Anaphylaxis Research (5 papers), Long-Term Effects of COVID-19 (4 papers), T-cell and B-cell Immunology (3 papers), Drug-Induced Adverse Reactions (2 papers), Systemic Sclerosis and Related Diseases (1 paper) and Cytomegalovirus and herpesvirus research (1 paper). The work is most often cited by research in Infectious Diseases (737 citations), Immunology and Allergy (106 citations), Neurology (178 citations), Immunology (221 citations) and General Dentistry (3 citations). Iris Chang has collaborated with scholars based in United States, Switzerland and Türkiye. Frequent co-authors include Xiaoying Zhou, Xiaorui Han, Shu Cao, Kari Christine Nadeau, Bryan Bunning, Shu‐Chen Lyu, Vanitha Sampath, Laurie Elizabeth Kost, Mübeccel Akdiş and Pattraporn Satitsuksanoa. Their work appears in journals such as Allergy, Nature Communications, JCI Insight, Science Translational Medicine and Cell Reports Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.